Company News

Launch date Title
2020-08-03 Astrocyte-to-neuron conversion for Parkinson's disease treatment
2020-07-01 Exploring Antiviral Immune Response
2020-06-01 Therapeutic strategies against PDAC
2020-05-08 Examining CTL/NK-mediated cytotoxicity by ELISA
2020-04-08 Ferroptosis/Oxytosis Antibody Panel is launched
2020-03-03 New HMGB1 neutralizing antibody is released
2020-02-07 ACE2, receptor of SARS-CoV-2
2020-02-03 Tumor immune microenvironment (TIME)
2020-01-06 The best solution for PD-1/PD-L1 research
2019-12-16 Detecting the DAMPs in cancer therapy by HMGB1 ELISA kit
2019-11-07 Detecting MMPs and their non-ECM substrates
2019-10-04 Inflammasome & Pyroptosis Antibody Panels are released
2019-09-02 New antibodies for exosome isolation
2019-08-01 Pericytes, new therapeutic target for Alzheimer's disease?
2019-07-01 More than a biomarker, CA19-9 is a therapeutic target of pancreatic cancer
2019-06-03 Angiogenesis & MVD Antibody Panels are released
2019-05-02 Inflammation antibody panels are released
2019-04-02 Hypoxia-induced transcription, histone demethylases are involved
2019-03-04 Cholesterol, the weakness of anaplastic large cell lymphoma (ALCL)
2019-02-21 See us at 2019 AACR in Atlanta

arigo nuts about antibodies
© 2014-2020, arigo Biolaboratories Corp., All rights reserved
沪ICP备17000949号-1